These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21310293)

  • 1. Drosophila models of Parkinson's disease.
    Whitworth AJ
    Adv Genet; 2011; 73():1-50. PubMed ID: 21310293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease.
    Whitworth AJ; Wes PD; Pallanck LJ
    Drug Discov Today; 2006 Feb; 11(3-4):119-26. PubMed ID: 16533709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dopaminergic neuronal dysfunction in genetic and toxin-induced models of Parkinson's disease in Drosophila.
    Navarro JA; Heßner S; Yenisetti SC; Bayersdorfer F; Zhang L; Voigt A; Schneuwly S; Botella JA
    J Neurochem; 2014 Nov; 131(3):369-82. PubMed ID: 25040725
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Nagoshi E
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coding mutations in
    Guo JF; Zhang L; Li K; Mei JP; Xue J; Chen J; Tang X; Shen L; Jiang H; Chen C; Guo H; Wu XL; Sun SL; Xu Q; Sun QY; Chan P; Shang HF; Wang T; Zhao GH; Liu JY; Xie XF; Jiang YQ; Liu ZH; Zhao YW; Zhu ZB; Li JD; Hu ZM; Yan XX; Fang XD; Wang GH; Zhang FY; Xia K; Liu CY; Zhu XW; Yue ZY; Li SC; Cai HB; Zhang ZH; Duan RH; Tang BS
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11567-11572. PubMed ID: 30348779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of
    Vos M; Klein C
    Cells; 2021 Mar; 10(3):. PubMed ID: 33800736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.
    Barone MC; Sykiotis GP; Bohmann D
    Dis Model Mech; 2011 Sep; 4(5):701-7. PubMed ID: 21719443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back.
    De Lazzari F; Bisaglia M; Zordan MA; Sandrelli F
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Parkinson's Disease: Lessons from Drosophila.
    Hewitt VL; Whitworth AJ
    Curr Top Dev Biol; 2017; 121():173-200. PubMed ID: 28057299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting UCH in Drosophila melanogaster as a model for Parkinson's disease.
    Thao DTP
    Front Biosci (Landmark Ed); 2020 Jan; 25(1):159-167. PubMed ID: 31585883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a presymptomatic stage in a Drosophila Parkinson's disease model: Unveiling dopaminergic compensatory mechanisms.
    Molina-Mateo D; Fuenzalida-Uribe N; Hidalgo S; Molina-Fernández C; Abarca J; Zárate RV; Escandón M; Figueroa R; Tevy MF; Campusano JM
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2882-2890. PubMed ID: 28716706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.
    Marcogliese PC; Abuaish S; Kabbach G; Abdel-Messih E; Seang S; Li G; Slack RS; Haque ME; Venderova K; Park DS
    Hum Mol Genet; 2017 Apr; 26(7):1247-1257. PubMed ID: 28158614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drosophila tubulin polymerization promoting protein mutants reveal pathological correlates relevant to human Parkinson's disease.
    Xie J; Chen S; Bopassa JC; Banerjee S
    Sci Rep; 2021 Jun; 11(1):13614. PubMed ID: 34193896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
    Xu Y; Xie M; Xue J; Xiang L; Li Y; Xiao J; Xiao G; Wang HL
    FASEB J; 2020 Apr; 34(4):5931-5950. PubMed ID: 32157731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling Parkinson's disease in Drosophila.
    Botella JA; Bayersdorfer F; Gmeiner F; Schneuwly S
    Neuromolecular Med; 2009; 11(4):268-80. PubMed ID: 19855946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learned from Drosophila models of Parkinson's disease?
    Guo M
    Prog Brain Res; 2010; 184():3-16. PubMed ID: 20887867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction.
    Vos M; Verstreken P; Klein C
    Biochem Soc Trans; 2015 Apr; 43(2):275-9. PubMed ID: 25849929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.